{"id":"W2492672367","doi":"10.1161/circulationaha.116.021887","title":"Sodium Glucose Cotransporter 2 Inhibitors in the Treatment of Diabetes Mellitus","year":2016,"lang":"en","type":"review","venue":"Circulation","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":1346,"is_retracted":false,"has_abstract":true,"ca_institutions":"Diabetes Canada; University of Toronto; Toronto General Hospital; St. Michael's Hospital; Mount Sinai Hospital","funders":"Canadian Institutes of Health Research","keywords":"Empagliflozin; Medicine; Internal medicine; Renal function; Diabetes mellitus; Tubuloglomerular feedback; Endocrinology; Kidney disease; Canagliflozin; Dapagliflozin; Cardiology; Blood pressure; Heart failure; Myocardial infarction; Type 2 diabetes; Urology","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0317982732403083,"score_gpt":0.2908156015844842,"score_spread":0.2590173283441759,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}